Follow CAP on Social Media

Listen to the CAP Podcast

Global Times: Africa and Latin America Will Prefer a Chinese-Made COVID-19 Vaccine

A package of the experimental vaccine test for the COVID-19 coronavirus is pictured at the Quality Control Laboratory at the Sinovac Biotech facilities in Beijing. NICOLAS ASFOURI / AFP

Chinese propaganda outlets are moving to frame the narrative that Chinese-made COVID-19 vaccines are better suited for developing countries compared to those made by U.S. and European organizations. 

“African and some Latin American countries would prefer Chinese-developed inactivated vaccines, due to their competitive costs and easier logistics, to stop their pandemic crisis,” said Global Times writer Hu Yuwei in an article published today.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?

Independent

The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.